Bromine in PDB 7pm2: Cryo-Em Structure of the Actomyosin-V Complex in the Rigor State (Central 1ER, Young Jasp-Stabilized F-Actin, Class 4)

The structure of Cryo-Em Structure of the Actomyosin-V Complex in the Rigor State (Central 1ER, Young Jasp-Stabilized F-Actin, Class 4) also contains other interesting chemical elements:

Magnesium

(Mg)

1 atom

The binding sites of Bromine atom in the Cryo-Em Structure of the Actomyosin-V Complex in the Rigor State (Central 1ER, Young Jasp-Stabilized F-Actin, Class 4) (pdb code 7pm2). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Cryo-Em Structure of the Actomyosin-V Complex in the Rigor State (Central 1ER, Young Jasp-Stabilized F-Actin, Class 4), PDB code: 7pm2:

Bromine binding site 1 out of 1 in the Cryo-Em Structure of the Actomyosin-V Complex in the Rigor State (Central 1ER, Young Jasp-Stabilized F-Actin, Class 4)


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Cryo-Em Structure of the Actomyosin-V Complex in the Rigor State (Central 1ER, Young Jasp-Stabilized F-Actin, Class 4) within 5.0Å range: probe atom residue distance (Å) B Occ C:Br404 b:101.1 occ:1.00 BR C:9UE404 0.0 101.1 1.0 C28 C:9UE404 1.9 101.1 1.0 N3 C:9UE404 2.8 101.1 1.0 C21 C:9UE404 3.0 101.1 1.0 CD2 C:HIC73 3.2 73.8 1.0 C19 C:9UE404 3.3 101.1 1.0 CZ C:HIC73 3.5 73.8 1.0 NE2 C:HIC73 3.5 73.8 1.0 C20 C:9UE404 3.6 101.1 1.0 N1 C:9UE404 3.9 101.1 1.0 C27 C:9UE404 4.0 101.1 1.0 C22 C:9UE404 4.1 101.1 1.0 CG C:HIC73 4.2 73.8 1.0 C18 C:9UE404 4.2 101.1 1.0 OD1 C:ASP179 4.2 73.7 1.0 C8 C:9UE404 4.4 101.1 1.0 CE1 C:HIC73 4.6 73.8 1.0 C9 C:9UE404 4.7 101.1 1.0 CB C:HIC73 4.9 73.8 1.0 CG C:ASP179 4.9 73.7 1.0 ND1 C:HIC73 5.0 73.8 1.0 C10 C:9UE404 5.0 101.1 1.0

S.Pospich, H.L.Sweeney, A.Houdusse, S.Raunser. High-Resolution Structures of the Actomyosin-V Complex in Three Nucleotide States Provide Insights Into the Force Generation Mechanism. Elife V. 10 2021.
ISSN: ESSN 2050-084X
PubMed: 34812732
DOI: 10.7554/ELIFE.73724